35 unchanged sentences
September 20, 2022, the Board approved the closure of the 2021 Financing.
−Removed: As of December 31, 2022, the Company had received 2021 Notes
−Removed: proceeds of $2,335,000, of which $525,000 is from a related party investor (a Company officer and Company director), however $1,260,000
−Removed: of these notes were converted to Series D-1 Preferred Shares during the 4 th quarter 2022.
−Removed: The remaining 2021 notes is $1,075,000.
−Removed: September 20, 2022, the Board approved a Financing Term Sheet (the “2022 Term Sheet”), which set forth the terms under which
−Removed: the Company will use its best efforts to arrange for financing of a maximum of $5,000,000 (the “2022 Financing”), which amounts
−Removed: will be obtained in several tranches.
−Removed: As of December 31, 2022, the Company had received 2022 Notes proceeds of $752,500, as defined below,
−Removed: of which $677,500 is from a related party investor (a Company director) in connection with the 2022 Financing.
+Added: Through December 31, 2023, the Company had received 2021
+Added: Notes proceeds of $2,335,000, of which $525,000 is from a related party investor (a Company officer and Company director), however
+Added: $1,260,000 of these notes were converted to Series D-1 Preferred Shares during the 4 th quarter 2022 and $875,000 of these
+Added: notes were converted to Series D-1 Preferred Shares during the year ended December 31, 2023.
+Added: As of December 31, 2023, the
+Added: remaining 2021 Note balance was $200,000.
+Added: September 20, 2022, the Board approved a Financing Term Sheet (the “2022 Term Sheet”), which set forth the terms under
+Added: which the Company will use its best efforts to arrange for financing of a maximum of $5,000,000 (the “2022 Financing”),
+Added: which amounts will be obtained in several tranches.
+Added: Through December 31, 2023, the Company had received 2022 Notes proceeds of
+Added: $3,227,500, as defined below, of which $2,352,500 is from a related party investor (a Company director), however, $752,500 of these
+Added: notes were converted to Series D-1 Preferred Shares during the year ended December 31, 2023.
+Added: As of December 31, 2023, the remaining
+Added: 2022 Notes balance was $2,475,000.
additional financing may not be available on acceptable terms, or at all.
7 unchanged sentences
is substantial doubt as to our ability to continue as a going concern.
−Removed: Company’s cash balance was $1,431,707 at December 31, 2022, which includes $1,410,102 of restricted cash resulting from a grant
−Removed: received from the State of Tennessee.
−Removed: The Company’s working capital deficiency was $6,293,198 and $4,258,679 as of December 31,
−Removed: 2022 and December 31, 2021, respectively.
+Added: Company’s cash balance was $1,026,799 at December 31, 2023, which includes $950,223 of restricted cash resulting from a grant received
+Added: from the State of Tennessee.
+Added: The Company’s working capital deficiency was $7,652,098 and $6,293,198 as of December 31, 2023 and
+Added: December 31, 2022, respectively.
The Company continues to incur significant operating losses and management expects that significant
182 unchanged sentences
business is presently managed by key Board members, employees, and independent contractors:
−Removed: (i) Ed Pershing, who is chairman of the Board,
−Removed: (ii) Dominic Rodrigues, who is vice chairman of the Board, (iii) Bruce Horowitz, our COO, who is an independent contractor, (iv) Eric
−Removed: Wachter, Ph.D., our Chief Technology Officer (“CTO”), who is an employee, and (v) Heather Raines, CPA, our CFO, who is an
+Added: (i) Ed Pershing, who is chairman of the
+Added: Board, (ii) Dominic Rodrigues, who is vice chairman of the Board and chief operations consultant, (iii) Eric Wachter, Ph.D., our Chief Technology Officer (“CTO”), who is an employee, and (iv) Heather Raines, CPA, our
+Added: CFO, who is an employee.
order to successfully execute our business plan, our management and Board must succeed in all of the following critical areas:
81 unchanged sentences
remove our current management.
−Removed: certificate of incorporation, as amended, and bylaws contain provisions that could delay or prevent a change of control of our company or changes
−Removed: in our board of directors that our stockholders might consider favorable.
−Removed: Among other things, these provisions will (i) permit our Board
−Removed: to issue up to 25,000,000 shares of preferred stock which can be created and issued by the Board without prior stockholder approval,
−Removed: with rights senior to those of the common stock, (ii) provide that all vacancies on our Board, including as a result of newly created
−Removed: directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office,
−Removed: even if less than a quorum, (iii) require that any action to be taken by our stockholders must be affected at a duly called annual or
−Removed: special meeting of stockholders and not be taken by written consent, (iv) provide that stockholders seeking to present proposals before
+Added: certificate of incorporation, as amended, and bylaws contain provisions that could delay or prevent a change of control of our company
+Added: or changes in our board of directors that our stockholders might consider favorable.
+Added: Among other things, these provisions will (i) permit
+Added: our Board to issue up to 25,000,000 shares of preferred stock which can be created and issued by the Board without prior stockholder
+Added: approval, with rights senior to those of the common stock, (ii) provide that all vacancies on our Board, including as a result of newly
+Added: created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in
+Added: office, even if less than a quorum, (iii) require that any action to be taken by our stockholders must be affected at a duly called annual
+Added: or special meeting of stockholders and not be taken by written consent, (iv) provide that stockholders seeking to present proposals before
a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice
2 unchanged sentences
requested by a majority of the Board to call such meetings.
−Removed: and other provisions in our certificate of incorporation, as amended, and bylaws and Delaware law could make it more difficult for
−Removed: stockholders or potential acquirers to obtain control of our Board or initiate actions that are opposed by our then-current Board,
−Removed: including delaying or impeding a merger, tender offer, or proxy contest involving our company.
−Removed: Any delay or prevention of a change
−Removed: of control transaction or changes in our Board could cause the market price of our common stock to decline.
+Added: and other provisions in our certificate of incorporation, as amended, and bylaws and Delaware law could make it more difficult for stockholders
+Added: or potential acquirers to obtain control of our Board or initiate actions that are opposed by our then-current Board, including delaying
+Added: or impeding a merger, tender offer, or proxy contest involving our company.
+Added: Any delay or prevention of a change of control transaction
+Added: or changes in our Board could cause the market price of our common stock to decline.
stock price is below $5.00 per share and is treated as a “penny stock,” which places restrictions on broker-dealers recommending
31 unchanged sentences
The Series D and Series D-1 Preferred Stock will have a first priority right to receive proceeds
−Removed: from the liquidation, winding-up or dissolution of us or certain mergers, corporate reorganizations or sales of our assets (each, a “Company
−Removed: If a Company Event occurs within two (2) years of the date of issuance of the Series D and Series D-1 Preferred Stock
−Removed: (the “Date of Issuance”), the holders of Series D and Series D-1 Preferred Stock will receive a preference of four times
−Removed: (4x) their respective investment amount.
−Removed: If a Company Event occurs after the second (2nd) anniversary of the Date of Issuance, the holders
−Removed: of the Series D and Series D-1 Preferred Stock will receive a preference of six times (6x) their respective investment amount.
−Removed: upon the occurrence of a Company Event, the holders of Series D and Series D-1 Preferred Stock would have the right to receive proceeds
−Removed: from any such transaction before our common stockholders.
−Removed: The payment of this preference could result in our common stockholders not
−Removed: receiving any consideration in connection with a Company Event.
−Removed: Related to SARS-CoV-2
−Removed: are subject to risks associated with a pandemic, epidemic or outbreak of a contagious disease, such as the ongoing SARS-CoV-2 pandemic,
−Removed: which may affect our future access to liquidity and materially adversely affect our business operations, results of operations and financial
−Removed: was reportedly first identified in late-2019 and subsequently declared a global pandemic by the World Health Organization on March 11,
−Removed: As a result of the SARS-CoV-2 pandemic, many companies have experienced disruptions of their operations and the markets they serve.
−Removed: The Company has taken several temporary precautionary measures intended to help ensure the well-being of its employees and contractors
−Removed: and to minimize business disruption.
−Removed: The Company considered the impact of SARS-CoV-2 pandemic on its business and operational assumptions
−Removed: and estimates, and determined there were no material adverse impacts on the Company’s results of operations and financial position
−Removed: at December 31, 2022.
−Removed: full extent of the SARS-CoV-2 pandemic impacts on the Company’s operations and financial condition is still uncertain.
−Removed: has experienced slower than normal enrollment and treatment of patients, and a prolonged SARS-CoV-2 pandemic could have a material adverse
−Removed: impact on the Company’s business and financial results, including the timing and ability of the Company to raise capital, initiate
−Removed: and/or complete current and/or future preclinical studies and/or clinical trials;
−Removed: disrupt the Company’s regulatory activities;
−Removed: and/or have other adverse effects on the Company’s clinical development.
−Removed: STAFF COMMENTS.
+Added: from the liquidation, winding-up or dissolution of us or certain mergers, corporate reorganizations, or sales of our assets (each, a
+Added: “Company Event”).
+Added: If a Company Event occurs within two (2) years of the date of issuance of the Series D and Series D-1 Preferred
+Added: Stock (the “Date of Issuance”), the holders of Series D and Series D-1 Preferred Stock will receive a preference of four
+Added: times (4x) their respective investment amount.
+Added: If a Company Event occurs after the second (2nd) anniversary of the Date of Issuance,
+Added: the holders of the Series D and Series D-1 Preferred Stock will receive a preference of six times (6x) their respective investment amount.
+Added: As a result, upon the occurrence of a Company Event, the holders of Series D and Series D-1 Preferred Stock would have the right to receive
+Added: proceeds from any such transaction before our common stockholders.
+Added: The payment of this preference could result in our common stockholders
+Added: not receiving any consideration in connection with a Company Event.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.